Northside Capital Management, LLC Vir Biotechnology, Inc. Transaction History

Northside Capital Management, LLC

  • $560 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 24, 2022
SELL
$30.97 - $54.03 $1.15 Million - $2.01 Million
-37,132 Closed
0 $0
Q1 2021

Apr 27, 2021
BUY
$26.34 - $83.07 $978,056 - $3.08 Million
37,132 New
37,132 $1.9 Million
Q3 2020

Oct 13, 2020
SELL
$28.28 - $53.6 $478,129 - $906,215
-16,907 Closed
0 $0
Q2 2020

Jul 15, 2020
BUY
$27.89 - $47.86 $471,536 - $809,169
16,907 New
16,907 $693,000

Others Institutions Holding VIR

# of Institutions
225
Shares Held
88.2M
Call Options Held
177K
Put Options Held
182K
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $1.17B
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Northside Capital Management, LLC Portfolio

Follow Northside Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northside Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Northside Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email